Lanzamiento Enero 2027

Ensayo controlado aleatorizado2026Financiación no declarada

Efficacy and Safety of High-Dose Vitamin D Supplementation Combined With an Enuresis Alarm vs Alarm Alone in Children With Primary Monosymptomatic Nocturnal Enuresis: A Randomized Clinical Trial

Ye Z, Luo X, Chen H, Zhang Q, Li C, Zhang Z, Wu S, Zhang D, Hua Y, Wei G, Liu X

The Journal of urology · 0 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2026-04-29 · J Urol · vol. 216 · número 2 · págs. 182–193
Editorial
Lippincott Williams & Wilkins
Citado
0 citas · más que el 26% de estudios similares · 0.0× el promedio de su campo
Referencias
0 trabajos
Acceso
De pago
Áreas de investigación
Pediatric Urology and Nephrology Studies · Urinary Bladder and Prostate Research · Vitamin D Research Studies
Palabras clave
primary monosymptomatic nocturnal enuresis, vitamin D supplementation, vitamin D insufficiency, 25-hydroxyvitamin D, children, treatment response, quality of life, treatment satisfaction, adverse events
MeSH
humans, vitamins, vitamin d, treatment outcome, combined modality therapy, quality of life, dietary supplements, child, female, male, nocturnal enuresis, clinical alarms

11 autores

  • Zihan Ye🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • X H Luo🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • Hongsong Chen🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • Qiang Zhang🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • Chang Li🇨🇳Children's Hospital of Chongqing Medical University
  • Z Zhang🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • Shengde Wu🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • Deying Zhang🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • Yi Hua🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • Guanghui Wei🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University
  • Xing Liu🇨🇳Children's Hospital of Chongqing Medical University; Chongqing Medical University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Purpose

This study evaluated the efficacy and safety of high-dose vitamin D supplementation (VDS) combined with enuresis alarm (EA) therapy in children with primary monosymptomatic nocturnal enuresis (PMNE).

Materials and methods

A 2-arm randomized clinical trial was conducted at a tertiary center in China between December 2024 and May 2025. Children with PMNE and serum 25-hydroxyvitamin D levels below 30 ng/mL were randomly assigned to receive either 8 weeks of VDS (vitamin D3 soft capsules, 2400 IU/d) plus EA (VDS + EA group) or EA (EA group). The primary outcome was treatment response. Secondary outcomes included change in weekly frequency of wet nights, quality of life scores, and treatment satisfaction. Safety was assessed by recording treatment-emergent adverse events.

Results

A total of 304 children were assessed for eligibility, of whom 262 (130 in the VDS + EA group and 132 in the EA group) were included in the final analysis. Compared with the EA group, the VDS + EA group showed higher response rates (RR 1.22; 95% CI 1.01-1.49; P = .04), complete response rates (RR 1.54; 95% CI 1.10-2.15; P = .01), a greater reduction in weekly wet nights (median difference, 1; 95% CI, 0-2; P = .003), and greater improvements in quality of life and treatment satisfaction. No statistically significant difference in the risk of treatment-emergent adverse events was observed between groups.

Conclusions

High-dose VDS combined with EA was effective and well tolerated for treating PMNE in children with vitamin D insufficiency, supporting its potential as a promising therapeutic approach.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.